Lorenzo Ferri: Antigen Heterogeneity and the impact on Esophageal adenocarcinoma treatment

Lorenzo Ferri, Professor of Surgery and Oncology at McGill University, shared a post on X:

“Sam Klempner speaking at the McGill 7th Annual Upper GI cancer symposium on Antigen Heterogeneity and the impact on Esophageal adenocarcinoma treatment.”

Lorenzo Ferri, MD, PhD, is a Professor (Tenure) of Surgery and Oncology at McGill University – Faculty of Medicine and Health Sciences. He holds the David S. Mulder Chair of Surgery, specializing in complex foregut malignancies, and serves as the Head of the Division of Thoracic and Upper Gastrointestinal Surgery at McGill University Health Centre, as well as the Director of the Upper G.I. Cancer Program.

Samuel Klempner is a member of the faculty at Harvard Medical School and Massachusetts General Hospital. He conducts clinical trials and translational research focused on new targeted agents and immunotherapies, and is active in the gastroesophageal cancer community, serving on the advisory boards of Debbie’s Dream Foundation and Hope for Stomach Cancer.